N-substituted-pyrrolidines as inhibitors of MDM2-P-53 interactions
申请人:Hoffmann-La Roche Inc.
公开号:US08017607B2
公开(公告)日:2011-09-13
There are provided compounds of the formula
wherein X, Y, R1, R2, R3, R3, R4, and R5 are as described herein
and enantiomers and pharmaceutically acceptable salts and esters thereof which are useful as anticancer agents.